Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial.
Am J Trop Med Hyg
; 103(2): 855-863, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32394880
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunization, Secondary
/
Dengue
/
Dengue Vaccines
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Trop Med Hyg
Year:
2020
Type:
Article